recall
saveHikma Pharmaceuticals USA Inc. recall (Cls II)
community read0 votes
Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25 — Reason: Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds — Status: Ongoing
view source ↗Data sources
last refreshed 7m ago
Found something off?
same company · ±60 days · 6
- recallLupin Pharmaceuticals Inc. recall (Cls II)Aug 6, 2025
- recallLupin Pharmaceuticals Inc. recall (Cls II)Jul 30, 2025
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls II)Aug 20, 2025
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls II)Aug 20, 2025
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls II)Aug 20, 2025
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls II)Aug 20, 2025
comments(0)
5-min edit window · permanent after that